News

Q1 2023 Newsletter – Recombinant metabolising enzymes

Hypha’s Q1 2023 newsletter – Recombinant metabolising enzymes

In our Q1 2023 newsletter we focus on Hypha’s recombinant enzymes, in particular new innovations to our PolyCYPs platform.

Sign up at the bottom of the page in the link here to receive our quarterly newsletter by email.

Read newsletter
 

Biotransformation of pirfenidone to an oxidised metabolite which matches the CYP1A2 product.

More News

View All

Welcome to Iain Beattie

Welcome to Iain Beattie We’re delighted to welcome Iain Beattie to Hypha as Scientific Fellow in Biotransformation and MetID. Iain brings a wealth of expertise
Read More >

Ready to begin? Our scientists are available to talk through your requirements

Contact Us 2

Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.

Linkedin-in Twitter
What We Do

Metabolite Synthesis

Purification

Structure Elucidation & NMR

Certificates of Analysis

Late Stage Functionalisation

Custom Natural Product Synthesis

Contract Fermentation

Our Products

PolyCYPs+ Kits for Metabolites

PolyCYPs Kits for Late-Stage Oxidation

PolyCYPs+ Kit Instructions

Human AOX

Human FMOs

Our Science

One-Stop Metabolite Shop

Late Stage Chemical Synthesis

Mammalian Biotransformations

Microbial Biotransformation

Purification & Structure Elucidation

Recombinant Enzymes

Resources

Brochures

Case Studies

Publications

Cookie Policy | Privacy Policy | Supplier Code of Conduct Policy | Website Terms and Conditions
© Hypha Discovery 2021. All Rights Reserved. 

Don't forget to subscribe to our newsletter and blog!

Newsletter Signup
Which do you wish to signup for?